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The mammalian olfactory receptor neurons (ORNs), which harbor odorant receptors, are contained in the olfactory epithelium (OE) lining the upper area of the nasal cavity. ORNs have the unusual and characteristic ability to regenerate continuously throughout the lifetime, with dying olfactory neurons being replaced by newly generated ORNs [2] . However, it is thought that olfactory epithelium is degenerated due to toxic environmental effects, viruses, toxins, drugs, diseases or smoking [7] as well as ageing [18] .
Various growth factors [16] and anti-apoptotic agents [4] have been reported to be essential for olfactory neurogenesis and have been proposed as potential candidate therapeutic drugs for olfactory dysfunction. However, while promising data have been reported based on in vitro experiments, only a few studies using in vivo experiments have been reported [20] .
Bcl-2 was originally identified as a protein product of the proto-oncogene BCL-2 and increased Bcl-2 expression is a common feature of many types of human malignancies, indicating that Bcl-2 plays an important role in carcinogenesis [14] . The family of this proto-oncogene is vitally involved in the regulation of cell death, while Bcl-2 is widely expressed during embryonic development and has been shown to protect neurons from various types of cell death [9] [15] . Recent in vivo studies using transgenic mice have shown that Bcl-2 also has a neuro-protective effect in various pathological situations [8] . It has also been demonstrated that NSL-05-1609 revised Nibu K, et al Bcl-2 promotes regeneration of axons by an action occurring separately from its well-known anti-apoptotic activity [3] .
The successful gene delivery to the ORNs in the olfactory system by adenoviral vector has been reported by us as well as others [6] [5] . Encouraged by these results, we first investigated the potential of a novel strategy for introducing exogenous Bcl-2 into ORNs by using the Cre/loxP recombination system with an adenoviral vector [19] . The results presented here are expected to contribute to the development of clinical applications of the Bcl-2 gene transfer to the peripheral olfactory system for the treatment of olfactory dysfunction.
Recombinant adenovirus
The virus preparation of AxCALNLBcl-2 and AxCANcre has been described elsewhere [19] . Human Bcl-2 cDNA was kindly provided by Dr SJ Korsmeyer (Harvard Medical School, Boston, MA). The viruses were grown in HEK 293 cells and purified by CsCl gradient centrifugation. Virus titer was determined by plaque assay, and the concentrated virus was stored at -80°C.
Animals
Mice with a C57BL/6J background were originally purchased from the Jackson Laboratory (Bar Harbor, ME) and raised in our animal facility. Adult 35-day-old male animals were used in this study. 
Bulbectomy
For unilateral bulbectomy, the animals were anesthetized by an intraperitoneal injection of 3.5% chloral hydrate (3.5mg/10g body weight) and clamped in a stereotactic apparatus (Narishige, Tokyo). The bone over the right olfactory bulb was removed and the ipsilateral bulb was totally removed by gentle suction as previously described [5] . Care was taken to avoid damage to the contralateral olfactory bulb. The animals were then sutured and allowed to recover from anesthesia on a warming pad. The extent of each lesion was verified by microscopic examination of fixed specimens. After recovery from anesthesia, mice were maintained on a normal diet until sacrifice at 2 and 5 days after the surgery.
Control and surgically lesioned mice were re-anesthetized and transcardially perfused with a solution of 4% paraformaldehyde, buffered to PH 7.4 with 0.1M phosphate buffer (PB). After perfusion, the nasal cavity containing the olfactory turbinates and septum was dissected and post-fixed in the same fixative solution for 2h.
Immunohistochemical analysis 7
Seven-micron-thick serial sections were cut from formalin-fixed paraffin-embedded specimens and mounted on silan coated slides (Dako Japan, Tokyo). Deparaffinized and rehydrated tissue was placed in a citrate-buffered solution (pH 6.0) and microwaved to 100°C for 20 min (antigen retrieval) as previously described.
Endogenous peroxidase and nonspecific binding was blocked with 3% hydrogen peroxide and 10% normal serum respectively. To detect the expression of bcl-2, the mouse monoclonal antibody against human Bcl-2 (Dako, Denmark) was diluted to 1:200 and incubated for one hour at room temperature. To identify the mature olfactory receptor neurons, the goat polyclonal antibody against OMP (Wako Pure Chemical Industries, Osaka) was diluted to 1:4000.
Immunoreactivity was detected with a Vectastain ABC kit (Vector Laboratories, Burlingame, CA). Normal serum was substituted for the primary antibody in negative controls. Diaminobenzidine (DAB) was used as the chromogen and nuclei were counterstained with hematoxylin.
Detection of Apoptotic Cells (TUNEL method)
Cell death resulting from apoptosis was measured using the terminal deoxynucleotidyl transferase mediated dUTP-biotin nick end labeling (TUNEL) method. Briefly, 7μ-thick serial sections were cut from formalin-fixed paraffin-embedded specimens and mounted on silan coated slides (Dako, Japan). Sections were deparaffinized and rehydrated through graded xylene and alcohol series followed by incubation with proteinase K (20 mg/mL in 10mM NSL-05-1609 revised At least six fields per each section were examined at a magnification of x 400 under a Nikon microscope. Statistical analysis was performed using Student's t-test. P<0.05 was considered statistically significant.
Exogenous expression of Bcl-2 gene
Microscopic examinations disclosed positive staining for Bcl-2 protein in the OE from post-infection day 1. The staining was predominantly observed in the upper layer of the OE (Fig. 1) . Close observation identified positive staining not only in the ORNs and globose basal cells but also in the supporting cells. However, no expression was detected in the horizontal basal cells on the basal lamina or in the olfactory nerve bundles in the lamina propria (Fig.2) . In addition, no toxic effects of adenoviral vectors were observed as they were in normal control. The expression of Bcl-2 was observed at least until post-infection day 8.
The role of exogenous Bcl-2 in protecting the ORNs against apoptosis induced by bulbectomy
To determine whether adenovirus-mediated overexpression of Bcl-2 induced by Cre/loxP system could protect ORNs against apoptotic stimuli, we examined the OE, which had already been infected with AxCALNLBcl-2 and AxCANCre, for bulbectomy-induced apoptosis.
Administration of adenoviral vectors was performed as described above. Bulbectomy was performed 7 days after the infection, and mice were sacrificed at post-bulbectomy days 2 and 5. The apoptotic cells on post-bulbectomy day 2 were detected using TUNEL method. As shown in Fig. 3, marginal The Cre/loxP recombination system has been successfully utilized in a gene activation and inactivation strategy not only in vitro but also in vivo. In fact, we previously used the Cre/loxP recombination system to demonstrate in vivo Bcl-2 expression in motor neurons in mice. However, the applications of this system are still limited because gene activation by Cre recombinase could be attained in only part of the targeted cells [19] . In fact, the number of ORNs expressing bcl-2 was significantly fewer than that of ORNs expressing LacZ in our previous study using the standard adenoviral vector [5] . In terms of its effect of neruoprotection, the survival benefit of exogenous Bcl-2 was expected from the findings at post-bulbectomy day 2 and 5, while statistical analysis did not reach to significance. These results suggest that bcl-2 might have a neuro-protective effect on the ORNs, but, as of now, the Cre/loxP system is not yet capable of delivering sufficient amounts of this gene to the peripheral olfactory system.
Conclusions
Although further studies are required for clinical application, the results of our study suggest that this strategy may be able to deliver exogenous Bcl-2 for the treatment of degeneration of olfactory receptor neurons. 
